July 1, 2017
Test Inventor and Founder Dr. Everson Accepts Role as CEO
HepQuant Test Inventor and Founder Doctor Gregory T. Everson Accepts Position of CEO DENVER (July 1, 2017) — HepQuant, LLC, a Greenwood Village, Colo.-based company with a unique, patented and patent-pending technology for evaluating the liver in patients with chronic liver disease, today announced that its liver test inventor, Dr. Greg…
April 15, 2017
Dr. Steve Helmke Appointed Chief Scientific Officer
March 21, 2017
HepQuant Announces Approval of 3rd IDE
March 17, 2017
HepQuant Announces Approval of 2nd IDE
March 9, 2017